AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney… EP News Bureau May 13, 2026 AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of…
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030:… EP News Bureau May 18, 2021 Historically, the CKD-HPT, HP, and HK disease space mainly consisted of reformulations of existing drugs and repurposed drugs from…
